ferrous sulfate has been researched along with Parkinson Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tai, KK; Truong, DD | 1 |
| Campbell, NR; Goodridge, AE; Hasinoff, BB; Kara, M; Rankine, D | 1 |
| Agid, Y; Carter, CJ; Dexter, DT; Javoy-Agid, F; Jenner, P; Lees, A; Marsden, CD; Wells, FR | 1 |
3 other study(ies) available for ferrous sulfate and Parkinson Disease
| Article | Year |
|---|---|
Activation of adenosine triphosphate-sensitive potassium channels confers protection against rotenone-induced cell death: therapeutic implications for Parkinson's disease.
Topics: Adenosine Triphosphate; Animals; Cell Death; Dose-Response Relationship, Drug; Electron Transport Complex I; Ferrous Compounds; Glyburide; Ischemic Preconditioning; Mitochondria; NADH, NADPH Oxidoreductases; Neurons; Parkinson Disease; Parkinson Disease, Secondary; PC12 Cells; Pinacidil; Potassium Channel Blockers; Potassium Channels; Protein Synthesis Inhibitors; Rats; Rotenone; Uncoupling Agents; Vasodilator Agents; Xanthine; Xanthine Oxidase | 2002 |
Sinemet-ferrous sulphate interaction in patients with Parkinson's disease.
Topics: Adult; Aged; Antiparkinson Agents; Biological Availability; Carbidopa; Drug Combinations; Drug Interactions; Female; Ferrous Compounds; Humans; Levodopa; Male; Middle Aged; Oxygen; Parkinson Disease | 1990 |
Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease.
Topics: Aged; Animals; Ascorbic Acid; Brain; Fatty Acids, Unsaturated; Female; Ferrous Compounds; Free Radicals; Humans; Hydrogen Peroxide; Lipid Peroxidation; Male; Malondialdehyde; Parkinson Disease; Postmortem Changes; Rats; Rats, Inbred Strains; Substantia Nigra; Thiobarbiturates | 1989 |